Female Sexual Function Following Radical Cystectomy in Bladder Cancer.


Journal

Sexual medicine reviews
ISSN: 2050-0521
Titre abrégé: Sex Med Rev
Pays: Netherlands
ID NLM: 101614773

Informations de publication

Date de publication:
04 2022
Historique:
received: 16 08 2021
revised: 27 09 2021
accepted: 06 10 2021
pubmed: 8 1 2022
medline: 13 4 2022
entrez: 7 1 2022
Statut: ppublish

Résumé

A clear and well-documented gender bias exists in the evaluation of sexual outcomes for women undergoing urologic surgery. Due to the anatomic template of anterior exenteration, women are commonly left with side effects that include sexual dysfunction and the perpetuated effects of surgical menopause. To present evaluation and treatment recommendations for female sexual dysfunction treatment and evaluation, in addition to surgical templates during radical cystectomy (RC). This article reviews current literature regarding sexual function and RC with urinary diversion in female bladder cancer patients. Furthermore, this review will provide a review of techniques for organ and neurovascular preservation, along with novel vaginal reconstruction templates. Our review will further focus on emerging technology, including minimally invasive surgery and organ and nerve preservation, directed at preservation of female sexual function. Clinically, studies have demonstrated that females who have undergone genitalia-sparing and neurovascular preservation during RC regained sexual activity earlier than patients undergoing traditional RC. If organ and nerve preservation is not feasible due to involvement of trigone or bladder neck, vaginal reconstruction can mitigate the sexual dysfunction that results from a loss of the anterior vagina during a standard RC. Female sexual dysfunction is associated with high levels of patient distress and is best comanaged with a multidisciplinary treatment approach, including preoperative counseling, intraoperative nerve, and organ preservation, and postoperative interventions to mitigate sexual side effects. Davis L, Isali I, Prunty M, et al. Female Sexual Function Following Radical Cystectomy in Bladder Cancer. Sex Med Rev 2022;10:231-239.

Identifiants

pubmed: 34992003
pii: S2050-0521(21)00090-1
doi: 10.1016/j.sxmr.2021.10.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-239

Informations de copyright

Copyright © 2021 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Laura Davis (L)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Ilaha Isali (I)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Megan Prunty (M)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Adam Calaway (A)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Case Comprehensive Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH, USA.

Kirtishri Mishra (K)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Case Comprehensive Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH, USA.

April Miller (A)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Rachel Pope (R)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Department of Reproduction Biology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Diana Magee (D)

Fox Chase Cancer Center, Division of Urologic Oncology, Philadelphia, PA, USA.

Alberto Castro Bigalli (AC)

Fox Chase Cancer Center, Division of Urologic Oncology, Philadelphia, PA, USA.

Nannan Thirumavalavan (N)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Lee Ponsky (L)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Case Comprehensive Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH, USA.

Laura Bukavina (L)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Fox Chase Cancer Center, Division of Urologic Oncology, Philadelphia, PA, USA. Electronic address: Laura.Bukavina@FCCC.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH